Cardinal Health, Inc. (CAH) Financial Statements
Historical financial data — 44 statements covering FY2016–FY2026
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail c...
Cardinal Health, Inc.'s revenue increased 14.2% year over year, from $222.58B to $254.25B.
Net income increased 9.8% over the same period, from $1.56B to $1.71B.
Over the 10-year period from FY2016 to FY2026, revenue grew by 109% in total.
Total debt increased by 17.3% to $10.00B.
Operating cash flow grew 115.9% to $5.17B.
Cardinal Health, Inc. maintains a moderate net profit margin of 0.7%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2025 | $52.28B-12.4% | $416.0M | $1.90B | $568.0M | $-1.65B | $43.06B | $5.16B | $-3.28B |
| Q2 FY2025 | $55.26B+5.7% | $400.0M | $1.94B | $549.0M | $-400.0M | $47.00B | $7.61B | $-2.99B |
| Q3 FY2025 | $54.88B-0.7% | $506.0M | $2.12B | $730.0M | $2.92B | $49.87B | $7.68B | $-2.95B |
| Q4 FY2025 | $60.16B+9.6% | $239.0M | $2.20B | $428.0M | $1.53B | $53.12B | $8.53B | $-2.78B |
| Q1 FY2026 | $64.01B+6.4% | $450.0M | $2.32B | $668.0M | $973.0M | $55.23B | $9.03B | $-2.88B |
| Q2 FY2026 | $65.63B+2.5% | $467.0M | $2.40B | $707.0M | $686.0M | $58.08B | $9.03B | $-2.88B |
| Q3 FY2026 | $60.94B-7.1% | $399.0M | $2.50B | $509.0M | $1.82B | $56.69B | $8.92B | $-2.67B |
| Q4 FY2026 | $63.67B+4.5% | $398.0M | $2.56B | $729.0M | $1.69B | $57.30B | $10.00B | $-2.72B |
Balance Sheet Summary (FY2026)
Cardinal Health, Inc. (CAH) Financial Statements & Revenue History
Cardinal Health, Inc. (CAH) is a US-listed stock operating in the Healthcare sector, specifically the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry trading at $253.10 with a market capitalization of $59. This page provides 44 historical financial statements for Cardinal Health, Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Cardinal Health, Inc. reported revenue of $254.2 billion, representing 14.2% year-over-year growth. The net profit margin of 0.7% suggests thin margins..
CAH Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Cardinal Health, Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether CAH is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track CAH's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Cardinal Health, Inc. converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of CAH's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use CAH Financial Data
Investors use Cardinal Health, Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare CAH's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how CAH's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View CAH's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Cardinal Health, Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.CAH trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.